Rachel Ewers, - Occupational Therapist in Lynchburg, VA

Rachel Ewers, is a Occupational Therapist based in Lynchburg, Virginia. Rachel Ewers is licensed to practice in Virginia (license number 0119000732) and her current practice location is 4657 Alabama Ave, Lynchburg, Virginia. She can be reached at her office (for appointments etc.) via phone at (434) 237-4932.

NPI number for Rachel Ewers is 1053728626 and her current mailing address is 4657 Alabama Ave, Lynchburg, Virginia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1053728626.

Contact Information

Rachel Ewers,
4657 Alabama Ave,
Lynchburg, VA 24502-1107
(434) 237-4932
Not Available



Healthcare Provider's Profile

Full NameRachel Ewers
GenderFemale
SpecialityOccupational Therapist
Location4657 Alabama Ave, Lynchburg, Virginia
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1053728626
  • Provider Enumeration Date: 07/16/2014
  • Last Update Date: 07/16/2014

Medical Identifiers

Medical identifiers for Rachel Ewers such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053728626NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225X00000XOccupational Therapist 0119000732 (Virginia)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rachel Ewers is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Rachel Ewers,
4657 Alabama Ave,
Lynchburg, VA 24502-1107

Ph: () -
Rachel Ewers,
4657 Alabama Ave,
Lynchburg, VA 24502-1107

Ph: (434) 237-4932

News Archive

Novel gene therapy control system regulates expression of therapeutic transgenes

Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.

Dynavax announces European development strategy for investigational adult hepatitis B vaccine in Europe

Dynavax Technologies Corporation (Nasdaq:DVAX) today announced that it has met with the European Medicines Evaluation Agency (EMEA) to discuss its plans for continued clinical development of HEPLISAVTM Phase 3 investigational adult hepatitis B vaccine in Europe.

Individual cells react differently to complex signals: Study

Using new technology that allows scientists to monitor how individual cells react in the complex system of cell signaling, Stanford University researchers have uncovered a much larger spectrum of differences between each cell than ever seen before.

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.

Millennium Labs founder receives Ernst & Young award in Life Sciences category

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, has received the Ernst & Young Entrepreneur of the Year 2011 San Diego Award in the Life Sciences category.

Read more News

› Verified 8 days ago


Occupational Therapist in Lynchburg, VA

Mrs. Amanda Barbara Anthony, MS, OTR/L
Occupational Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 3300 Rivermont Ave, Lynchburg, VA 24503
Phone: 434-200-4668    
Laura D Winch,
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501
Phone: 434-200-3037    
Deborah Friedman, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 401 Monticello Ave, Lynchburg, VA 24501
Phone: 434-515-5170    
Sandra E Luse,
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 693 Leesville Rd, Lynchburg, VA 24502
Phone: 434-947-5700    
Ashley Nicole Mooney, OTR/L
Occupational Therapist
Medicare: Medicare Enrolled
Practice Location: 2405 Atherholt Rd, Lynchburg, VA 24501
Phone: 804-915-1910    
Kimberly Cottrell,
Occupational Therapist
Medicare: Medicare Enrolled
Practice Location: 101 Leroy Bowen Dr Ste A, Lynchburg, VA 24502
Phone: 434-239-6630    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.